SARS-CoV-2 evolution and immune escape in immunocompromised patients treated with exogenous antibodies

Erin M. Scherer, Ahmed Babiker, Max W. Adelman, Brent Allman, Autum Key, Jennifer M. Kleinhenz, Rose M. Langsjoen, Phuong-Vi Nguyen, Ivy Onyechi, Jacob D. Sherman, Trevor W. Simon, Hannah Soloff, Jessica Tarabay, Jay Varkey, Andrew S. Webster, Daniela Weiskopf, Daniel B. Weissman, Yongxian Xu, Jesse J. Waggoner, Katia Koelle, Nadine Rouphael, Stephanie M. Pouch, Anne Piantadosi
doi: https://doi.org/10.1101/2022.04.12.22273675

Article Information

doi 
https://doi.org/10.1101/2022.04.12.22273675
History 
  • April 19, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Erin M. Scherer, Ph.D., D.Phil.1,2,*,
  2. Ahmed Babiker, M.B.B.S.1,3,
  3. Max W. Adelman, M.D.1,
  4. Brent Allman, B.A.4,
  5. Autum Key, M.S.3,
  6. Jennifer M. Kleinhenz, B.S.2,5,
  7. Rose M. Langsjoen, Ph.D.3,
  8. Phuong-Vi Nguyen1,
  9. Ivy Onyechi, M.S.6,
  10. Jacob D. Sherman, B.S.1,2,
  11. Trevor W. Simon, M.S.1,2,
  12. Hannah Soloff7,
  13. Jessica Tarabay, M.P.H.8,
  14. Jay Varkey, M.D.1,
  15. Andrew S. Webster, M.D.1,
  16. Daniela Weiskopf, Ph.D.9,
  17. Daniel B. Weissman, Ph.D.10,11,
  18. Yongxian Xu, M.D.1,2,
  19. Jesse J. Waggoner, M.D.1,
  20. Katia Koelle, Ph.D.11,
  21. Nadine Rouphael, M.D.1,2,
  22. Stephanie M. Pouch, M.D., M.S.1 and
  23. Anne Piantadosi, M.D., Ph.D.1,3,*
  1. 1Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
  2. 2Hope Clinic of the Emory Vaccine Center, Emory University School of Medicine, Decatur, GA, USA
  3. 3Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA
  4. 4Population Biology, Ecology, and Evolution Graduate Program, Laney Graduate School, Emory University, Atlanta, GA, USA
  5. 5Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA
  6. 6Emory Integrated Genomics Core, Emory University, Atlanta, GA, USA
  7. 7Emory University, Atlanta, GA, USA
  8. 8Emory Healthcare
  9. 9Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA
  10. 10Department of Physics, Emory University, Atlanta, GA, USA
  11. 11Department of Biology, Emory University, Atlanta, GA, USA
  1. ↵*Corresponding Authors:
    Erin M. Scherer, Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Hope Clinic of the Emory Vaccine Center, Emory University School of Medicine erin.margaret.scherer{at}emory.edu, Anne Piantadosi, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, anne.piantadosi{at}emory.edu
Back to top
Posted April 19, 2022.
Download PDF
Data/Code
Email
SARS-CoV-2 evolution and immune escape in immunocompromised patients treated with exogenous antibodies
Erin M. Scherer, Ahmed Babiker, Max W. Adelman, Brent Allman, Autum Key, Jennifer M. Kleinhenz, Rose M. Langsjoen, Phuong-Vi Nguyen, Ivy Onyechi, Jacob D. Sherman, Trevor W. Simon, Hannah Soloff, Jessica Tarabay, Jay Varkey, Andrew S. Webster, Daniela Weiskopf, Daniel B. Weissman, Yongxian Xu, Jesse J. Waggoner, Katia Koelle, Nadine Rouphael, Stephanie M. Pouch, Anne Piantadosi
medRxiv 2022.04.12.22273675; doi: https://doi.org/10.1101/2022.04.12.22273675
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area